solutol hs 15 has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Auti, ST; Kulkarni, YA; Kunde, SS; Raju, M; Wairkar, S | 1 |
| Dave, KR; Gresia, VL; Lin, HW; Neumann, JT; Perez-Pinzon, MA; Saul, I | 1 |
| Casu, GL; Fadda, P; Lazzari, P; Marchese, G; Pani, L | 1 |
3 other study(ies) available for solutol hs 15 and Disease Models, Animal
| Article | Year |
|---|---|
Berberine loaded nanostructured lipid carrier for Alzheimer's disease: Design, statistical optimization and enhanced in vivo performance.
Topics: Alzheimer Disease; Animals; Avoidance Learning; Berberine; Biological Availability; Disease Models, Animal; Drug Carriers; Drug Design; Locomotion; Male; Morris Water Maze Test; Nanoparticles; Particle Size; Polyethylene Glycols; Rats; Rats, Wistar; Spatial Memory; Stearic Acids; Surface-Active Agents; Triglycerides | 2021 |
Fatty acid methyl esters and Solutol HS 15 confer neuroprotection after focal and global cerebral ischemia.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Palmitates; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Stearic Acids; Vasodilator Agents | 2014 |
Antinociceptive activity of Delta9-tetrahydrocannabinol non-ionic microemulsions.
Topics: Administration, Oral; Analgesics; Animals; Chemistry, Pharmaceutical; Disease Models, Animal; Dronabinol; Drug Compounding; Drug Stability; Emulsions; Injections, Intraperitoneal; Male; Mice; Pain; Pain Measurement; Pain Threshold; Polyethylene Glycols; Reaction Time; Solubility; Stearic Acids; Surface-Active Agents; Technology, Pharmaceutical; Temperature; Time Factors | 2010 |